Diabetes & Endocrinology News

• The Rocky Path to Parenthood During Cardiology Training An international survey found significant variation in parental leave policies, including scant time off for trainees in the US and Asia vs other countries.
  Medscape Medical News, May 23, 2022
• SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes? Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.
  Medscape Medical News, May 23, 2022
• Fewer Teens Giving Birth, but Cases Are More Complex Rates of obesity, mental health conditions, diabetes, and delivery complications have increased among teens giving birth.
  Medscape Medical News, May 23, 2022
• EuroPCR 2022 ACURATE neo2 Paravalvular Leaks Plummet vs Predecessor New real-world registry data comparing the redesigned valve to the first-generation ACURATE neo suggest that small changes can lead to big improvements.
  Medscape Medical News, May 23, 2022
• When Should Those With End-Stage Kidney Disease Forego Dialysis? Australia and the UK have long had programs whereby some elderly patients with end-stage kidney disease, or those with many comorbidities, opt to forego dialysis, but the US has lagged behind.
  Medscape Medical News, May 23, 2022
• ESC-HF Moderate to High Alcohol Use May Push 'Pre-HF' Into Clinical HF Also, no protection was evident at any alcohol-intake level among STOP-HF trial participants who were initially at risk for heart failure but without echocardiographic signs of the disease.
  Medscape Medical News, May 23, 2022
• Tirzepatide's Retail Price Set at About $12,666 Per Year The recently approved twincretin will carry a US retail price similar to one of its main competitors, semaglutide, but patient discounts will be available.
  Medscape Medical News, May 20, 2022
• Aspirin Links With CVD Cut in Patients With Kidney Disease Recent recommendations advise against aspirin for primary prevention of CVD events in people over 59 years old, but when chronic kidney disease is present it looks like a different story.
  Medscape Medical News, May 20, 2022
• Erectile Dysfunction in Diabetes May Be Underestimated Erectile dysfunction is common even among men within a year of their diabetes diagnosis. A researcher from the German Diabetes Center discusses what is known about this problem.
  Medscape Medical News, May 20, 2022
• AACE 2022 Debate Continues on Combination Therapy for Hypothyroidism Clinicians shouldn't dismiss patients who complain about residual symptoms despite TSH normalization with levothyroxine, say thyroid experts who have rekindled a long-running debate at the AACE meeting.
  Medscape Medical News, May 20, 2022
• Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone Men with metastatic disease who received enzalutamide demonstrated a small but significant survival benefit. The study was published as a preprint and has not yet been peer reviewed.
  Medscape Medical News, May 20, 2022
• Many Americans Missing an Opportunity to Prevent Dementia Nearly half of all US adults aged 45 and older have modifiable risk factors for Alzheimer's and related dementia, including high blood pressure, low levels of physical activity, and obesity.
  Medscape Medical News, May 20, 2022
• Pancreatic Involvement in COVID-19: What Do We Know? Data indicate that the pancreas as a target of SARS-CoV-2 infection and suggest that pancreatic beta cell involvement could contribute to the metabolic dysregulation seen in patients with COVID-19.
  Medscape Medical News, May 19, 2022
• Drinking More Coffee May Reduce Acute Kidney Injury Risk Increased consumption of coffee may reduce the risk of developing acute kidney injury, reports a prospective cohort study.
  Medscape Medical News, May 19, 2022
• Patients' Bad Behavior Provokes Burnout in Physicians: Study Mistreatment and discrimination by patients increase the risk of physician burnout; for 1 in 5 physicians, patients refused care because of the physician's appearance.
  Medscape Medical News, May 19, 2022
• Could New Therapy for Food 'Cues' Improve Weight Loss? Patients highly sensitive to food 'cues' may benefit from a behavioral therapy, a trial hints. However, the intervention is labor-intensive and associated with modest weight loss, two experts point out.
  Medscape Medical News, May 19, 2022
• Hormones Account for 10% of Lipid Changes After Menopause The transition to menopause is accompanied by a proatherogenic shift in lipids and other metabolites, and new research directly implicates the hormonal shift at this stage of life to some of these changes.
  Medscape Medical News, May 18, 2022
• Diabetic Retinopathy Risk, Severity Show Socioeconomic Links Low income and type of health insurance was associated with an increased prevalence of medical risk factors for diabetic retinopathy as well as the risk for vision-threatening disease.
  First Look, May 18, 2022
• AACE 2022 Biotin: Good for Hair and Nails, Bad for Thyroid Lab Tests New study supports prior finding that about 7% of the population uses products containing biotin in doses high enough to interfere with many laboratory tests, including those of thyroid function.
  Medscape Medical News, May 18, 2022
• Alabama Transgender Youth Can Use Medicine During Transition: Judge Transgender minors in Alabama for now can use medicine to transition, a federal judge said late on Friday in an order that blocked part of a state ban on gender-affirming treatments.
  Reuters Health Information, May 16, 2022